1. Home
  2. ALGT vs CAPR Comparison

ALGT vs CAPR Comparison

Compare ALGT & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGT
  • CAPR
  • Stock Information
  • Founded
  • ALGT 1997
  • CAPR 2005
  • Country
  • ALGT United States
  • CAPR United States
  • Employees
  • ALGT N/A
  • CAPR N/A
  • Industry
  • ALGT Air Freight/Delivery Services
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ALGT Consumer Discretionary
  • CAPR Health Care
  • Exchange
  • ALGT Nasdaq
  • CAPR Nasdaq
  • Market Cap
  • ALGT 750.0M
  • CAPR 600.7M
  • IPO Year
  • ALGT 2006
  • CAPR N/A
  • Fundamental
  • Price
  • ALGT $50.22
  • CAPR $8.26
  • Analyst Decision
  • ALGT Hold
  • CAPR Strong Buy
  • Analyst Count
  • ALGT 10
  • CAPR 7
  • Target Price
  • ALGT $65.70
  • CAPR $40.14
  • AVG Volume (30 Days)
  • ALGT 367.7K
  • CAPR 2.5M
  • Earning Date
  • ALGT 07-30-2025
  • CAPR 08-06-2025
  • Dividend Yield
  • ALGT N/A
  • CAPR N/A
  • EPS Growth
  • ALGT N/A
  • CAPR N/A
  • EPS
  • ALGT N/A
  • CAPR N/A
  • Revenue
  • ALGT $2,555,257,000.00
  • CAPR $17,363,588.00
  • Revenue This Year
  • ALGT $8.29
  • CAPR $258.96
  • Revenue Next Year
  • ALGT $10.80
  • CAPR $8.02
  • P/E Ratio
  • ALGT N/A
  • CAPR N/A
  • Revenue Growth
  • ALGT 1.54
  • CAPR N/A
  • 52 Week Low
  • ALGT $36.09
  • CAPR $3.52
  • 52 Week High
  • ALGT $107.57
  • CAPR $23.40
  • Technical
  • Relative Strength Index (RSI)
  • ALGT 41.92
  • CAPR 36.50
  • Support Level
  • ALGT $50.01
  • CAPR $11.57
  • Resistance Level
  • ALGT $54.50
  • CAPR $13.51
  • Average True Range (ATR)
  • ALGT 2.52
  • CAPR 1.70
  • MACD
  • ALGT -0.79
  • CAPR -0.33
  • Stochastic Oscillator
  • ALGT 2.74
  • CAPR 24.52

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: